Dan Veljovich, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    GSK
    Topic: 
    Parp inhibitor consulting and speaker's bureau
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca
    Topic: 
    Parp inhibitor consulting and speaker's bureau
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Eisai
    Topic: 
    Immunotherapy and TKI for uterine cancer
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Merck
    Topic: 
    Immunotherapy and TKI for uterine cancer
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    ADPT Adaptive BIotech
    Topic: 
    Stockholder
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    ABBV Abbvie
    Topic: 
    Stockholder
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    AZN AstraZeneca
    Topic: 
    Stockholder
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    CVS CVS Health
    Topic: 
    Stockholder
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    DOCS DOximity
    Topic: 
    Stockholder
    Date added: 
    08/24/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    GILD GIlead
    Topic: 
    Stockholder
    Date added: 
    08/24/2022

Pages

Return to Best of ASCO 2023, Portland